Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Dankner

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
JCO Precision Oncology|February 9, 2022
Targeted Therapy for Colorectal Cancers With Non-V600 BRAF Mutations: Perspectives for Precision OncologyMatthew Dankner
The Journal of Pathology. Clinical Research|March 22, 2020
Post-mortem tissue donation programs as platforms to accelerate cancer researchMatthew Dankner, Badia Issa-Chergui, Nathaniel Bouganim
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 6, 2020
An exercise in scientific writing for physicians in trainingHeather T Whittaker, Lashanda Skerritt, Matthew Dankner, et al.
Drugs in Context|May 11, 2023
Non-small-cell lung cancer: how to manage <i>BRAF</i>-mutated diseaseGiorgia Guaitoli, Lodovica Zullo, Marcello Tiseo, et al.
Oncogene|March 16, 2018
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutationsMatthew Dankner, April A N Rose, Shivshankari Rajkumar, et al.
Oncoimmunology|August 17, 2017
CEACAM1 as a multi-purpose target for cancer immunotherapyMatthew Dankner, Scott D Gray-Owen, Yu-Hwa Huang, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Antibody-Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System MetastasesDavid J H Bian, Sara F Cohen, Anna-Maria Lazaratos, et al.
Nature Reviews. Cancer|January 10, 2024
The role of CRAF in cancer progression: from molecular mechanisms to precision therapiesMelody Riaud, Jennifer Maxwell, Isabel Soria-Bretones, et al.
Neuro-Oncology Advances|October 26, 2022
Radiomics as an emerging tool in the management of brain metastasesAlexander Nowakowski, Zubin Lahijanian, Valerie Panet-Raymond, et al.
Cancers|February 13, 2021
The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid CancersMatthew Dankner, Stephanie Lam, Theresa Degenhard, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
JCO Precision Oncology|February 9, 2022
Targeted Therapy for Colorectal Cancers With Non-V600 BRAF Mutations: Perspectives for Precision OncologyMatthew Dankner
The Journal of Pathology. Clinical Research|March 22, 2020
Post-mortem tissue donation programs as platforms to accelerate cancer researchMatthew Dankner, Badia Issa-Chergui, Nathaniel Bouganim
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 6, 2020
An exercise in scientific writing for physicians in trainingHeather T Whittaker, Lashanda Skerritt, Matthew Dankner, et al.
Drugs in Context|May 11, 2023
Non-small-cell lung cancer: how to manage <i>BRAF</i>-mutated diseaseGiorgia Guaitoli, Lodovica Zullo, Marcello Tiseo, et al.
Oncogene|March 16, 2018
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutationsMatthew Dankner, April A N Rose, Shivshankari Rajkumar, et al.
Oncoimmunology|August 17, 2017
CEACAM1 as a multi-purpose target for cancer immunotherapyMatthew Dankner, Scott D Gray-Owen, Yu-Hwa Huang, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Antibody-Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System MetastasesDavid J H Bian, Sara F Cohen, Anna-Maria Lazaratos, et al.
Nature Reviews. Cancer|January 10, 2024
The role of CRAF in cancer progression: from molecular mechanisms to precision therapiesMelody Riaud, Jennifer Maxwell, Isabel Soria-Bretones, et al.
Neuro-Oncology Advances|October 26, 2022
Radiomics as an emerging tool in the management of brain metastasesAlexander Nowakowski, Zubin Lahijanian, Valerie Panet-Raymond, et al.
Cancers|February 13, 2021
The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid CancersMatthew Dankner, Stephanie Lam, Theresa Degenhard, et al.
Pageof 4